You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 19, 2024

FOSCAVIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Foscavir, and when can generic versions of Foscavir launch?

Foscavir is a drug marketed by Clinigen Hlthcare and is included in one NDA.

The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the foscarnet sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Foscavir

A generic version of FOSCAVIR was approved as foscarnet sodium by FRESENIUS KABI USA on January 29th, 2021.

  Try a Trial

Drug patent expirations by year for FOSCAVIR
Drug Prices for FOSCAVIR

See drug prices for FOSCAVIR

Recent Clinical Trials for FOSCAVIR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, LillePhase 2
BiotestPhase 2
National Cancer Institute (NCI)

See all FOSCAVIR clinical trials

Pharmacology for FOSCAVIR

US Patents and Regulatory Information for FOSCAVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FOSCAVIR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ⤷  Try a Trial ⤷  Try a Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ⤷  Try a Trial ⤷  Try a Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ⤷  Try a Trial ⤷  Try a Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for FOSCAVIR

See the table below for patents covering FOSCAVIR around the world.

Country Patent Number Title Estimated Expiration
Canada 1077848 COMPOSE ANTI-VIRAL CONTENANT DE L'ACIDE PHOSPHONOFORMIQUE (ANTI-VIRAL COMPOSITION CONTAINING PHOSPHONOFORMIC ACID) ⤷  Try a Trial
Singapore 80383 ⤷  Try a Trial
Luxembourg 77666 ⤷  Try a Trial
Bulgaria 60834 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.